Skip to main content

Table 1 Drugs included in the four investigated pharmaceutical groups, and number of people in a cohort of people with intellectual disability (ID) and a reference group from the general population (gPop) with at least one prescription during the study period

From: Pharmacotherapy for mood and anxiety disorders in older people with intellectual disability in comparison with the general population

 

gPop

ID

Anxiolytics

 N05BA01 diazepama

83

198

 N05BA02 chlordiazepoxidea

< 5

< 5

 N05BA04 oxazepama

157

264

 N05BA06 lorazepama

< 5

19

 N05BA09 clobazama

< 5

< 5

 N05BA12 alprazolama

42

58

 N05BB01 hydroxyzine

128

162

 N05 BC01 meprobamate

< 5

< 5

 N05BE01 buspirone

15

22

Hypnotics and sedatives

 N05CC01 chloral hydratea

< 5

< 5

 N05CD02 nitrazepama

26

43

 N05CD03 flunitrazepama

16

14

 N05CD05 triazolama

< 5

< 5

 N05CD08 midazolama

< 5

< 5

 N05CF01 zopiclonea

173

214

 N05CF02 zolpidema

112

83

 N05CF03 zaleplona

8

< 5

 N05CM02 clomethiazolea

< 5

57

 N05CM05 scopolamine

< 5

< 5

 N05CM06 propiomazine

164

186

 N05CM09 Valerianae radix

< 5

< 5

Antidepressants

 N06AA04 clomipramine

14

42

 N06AA06 trimipramine

< 5

< 5

 N06AA09 amitriptyline

43

34

 N06AA10 nortriptyline

5

< 5

 N06AA21 maprotiline

< 5

< 5

 N06AB03 fluoxetine

31

29

 N06AB04 citalopram

124

206

 N06AB05 paroxetine

19

33

 N06AB06 sertraline

100

127

 N06AB08 fluvoxamine

< 5

< 5

 N06AB10 escitalopram

73

88

 N06AF03 phenelzine

< 5

< 5

 N06AF04 tranylcypromine

< 5

< 5

 N06AG02 moclobemide

< 5

< 5

 N06AX02 tryptophan

< 5

< 5

 N06AX03 mianserin

25

27

 N06AX11 mirtazapine

148

141

 N06AX12 bupropion

27

16

 N06AX16 venlafaxine

78

54

 N06AX18 reboxetine

9

< 5

 N06AX21 duloxetine

59

33

 N06AX22 agomelatine

9

< 5

  1. aAlso included in the group “GABA-agonists”
Back to article page

BMC Psychiatry

ISSN: 1471-244X

Contact us